Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.
Report: Pharmaceutical Contract Manufacturing Market Expected to Hit $140 Billion by 2030
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours